What is a risk associated with exercise for clients with liver disease?

What is a risk associated with exercise for clients with liver disease?

• A. No risk; exercise is always safe.
• B. Increased risk of bleeding or bruising; avoid contact sports or high-impact exercises.
• C. Liver disease improves with any exercise.
• D. Only risk is dehydration.

Answer: (B)

Liver disease can disrupt blood clotting, which means exercising can carry a higher risk of bleeding or bruising. The liver produces most of the clotting factors the body uses to stop bleeding; when it isn’t working well, clotting factor levels fall and clotting times lengthen. Platelets may also be reduced or function abnormally because of portal hypertension, increasing the chance of bruising. Exercise can raise blood pressure, involve straining, or lead to falls or impacts, all of which can trigger bleeding more easily in someone with a tendency to bleed. Because of this elevated bleeding risk, avoiding contact sports or high‑impact activities is wise, and a safer plan emphasizes moderate, low‑impact exercise with medical clearance and monitoring. Other statements don’t capture the real risk clinicians worry about in liver disease, which centers on coagulopathy and bleeding rather than a universal safety or dehydration-only concern.

Liver disease can disrupt blood clotting, which means exercising can carry a higher risk of bleeding or bruising. The liver produces most of the clotting factors the body uses to stop bleeding; when it isn’t working well, clotting factor levels fall and clotting times lengthen. Platelets may also be reduced or function abnormally because of portal hypertension, increasing the chance of bruising. Exercise can raise blood pressure, involve straining, or lead to falls or impacts, all of which can trigger bleeding more easily in someone with a tendency to bleed. Because of this elevated bleeding risk, avoiding contact sports or high‑impact activities is wise, and a safer plan emphasizes moderate, low‑impact exercise with medical clearance and monitoring. Other statements don’t capture the real risk clinicians worry about in liver disease, which centers on coagulopathy and bleeding rather than a universal safety or dehydration-only concern.